NCT05917327 - Performance and Safety of MEX-CD1 Low-volume Continuous Veno-venous Haemodialysis Medical Device for Copper-extraction in Patients With Wilson's Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 24, 2024

Primary Completion Date

April 1, 2026

Study Completion Date

April 1, 2026

Conditions

Hepatolenticular Degeneration; Wilson

Interventions

DEVICE

Low-volume continuous veno-venous haemodialysis

MEX-CD1 is a hyper-chelating colloidal solution that can be added to the dialysate to be used in low-volume continuous veno-venous hemodialysis. One treatment will last 4 hours. For non-hospitalized patients, the treatment is performed on an outpatient basis.

Trial Locations (4)

69317

Hôpital Croix Rousse, Service d'hépatologie et gastroentérologie, Lyon

69500

Hôpital Femme Mère Enfant, Service des urgences et la réanimation pédiatriques, Bron

08035

Hospital Universitario Vall d'Hebron, Unitat de Trasplantament Hepàtic Pediàtric, Barcelona

08036

Hospital Clinic Barcelona, Liver ICU, Barcelona